Trichloroethylene and Perchloroethylene
The research report includes specific segments by region (country), by manufacturers, by Type and ... Read More
1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Molecular Diagnosis and Therapy Market Size Growth Rate by Type: 2017 VS 2021 VS 2028 1.2.2 PCR 1.2.3 DNA Sequencing 1.2.4 NGS 1.3 Market by Application 1.3.1 Global Molecular Diagnosis and Therapy Market Share by Application: 2017 VS 2021 VS 2028 1.3.2 Diagnostic Laboratories 1.3.3 Research & Academic Laboratories 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Molecular Diagnosis and Therapy Market Perspective (2017-2028) 2.2 Molecular Diagnosis and Therapy Growth Trends by Region 2.2.1 Molecular Diagnosis and Therapy Market Size by Region: 2017 VS 2021 VS 2028 2.2.2 Molecular Diagnosis and Therapy Historic Market Size by Region (2017-2022) 2.2.3 Molecular Diagnosis and Therapy Forecasted Market Size by Region (2023-2028) 2.3 Molecular Diagnosis and Therapy Market Dynamics 2.3.1 Molecular Diagnosis and Therapy Industry Trends 2.3.2 Molecular Diagnosis and Therapy Market Drivers 2.3.3 Molecular Diagnosis and Therapy Market Challenges 2.3.4 Molecular Diagnosis and Therapy Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Molecular Diagnosis and Therapy Players by Revenue 3.1.1 Global Top Molecular Diagnosis and Therapy Players by Revenue (2017-2022) 3.1.2 Global Molecular Diagnosis and Therapy Revenue Market Share by Players (2017-2022) 3.2 Global Molecular Diagnosis and Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.3 Players Covered: Ranking by Molecular Diagnosis and Therapy Revenue 3.4 Global Molecular Diagnosis and Therapy Market Concentration Ratio 3.4.1 Global Molecular Diagnosis and Therapy Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Molecular Diagnosis and Therapy Revenue in 2021 3.5 Molecular Diagnosis and Therapy Key Players Head office and Area Served 3.6 Key Players Molecular Diagnosis and Therapy Product Solution and Service 3.7 Date of Enter into Molecular Diagnosis and Therapy Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Molecular Diagnosis and Therapy Breakdown Data by Type 4.1 Global Molecular Diagnosis and Therapy Historic Market Size by Type (2017-2022) 4.2 Global Molecular Diagnosis and Therapy Forecasted Market Size by Type (2023-2028) 5 Molecular Diagnosis and Therapy Breakdown Data by Application 5.1 Global Molecular Diagnosis and Therapy Historic Market Size by Application (2017-2022) 5.2 Global Molecular Diagnosis and Therapy Forecasted Market Size by Application (2023-2028) 6 North America 6.1 North America Molecular Diagnosis and Therapy Market Size (2017-2028) 6.2 North America Molecular Diagnosis and Therapy Market Size by Country (2017-2022) 6.3 North America Molecular Diagnosis and Therapy Market Size by Country (2023-2028) 6.4 United States 6.5 Canada 7 Europe 7.1 Europe Molecular Diagnosis and Therapy Market Size (2017-2028) 7.2 Europe Molecular Diagnosis and Therapy Market Size by Country (2017-2022) 7.3 Europe Molecular Diagnosis and Therapy Market Size by Country (2023-2028) 7.4 Germany 7.5 France 7.6 U.K. 7.7 Italy 7.8 Russia 7.9 Nordic Countries 8 Asia-Pacific 8.1 Asia-Pacific Molecular Diagnosis and Therapy Market Size (2017-2028) 8.2 Asia-Pacific Molecular Diagnosis and Therapy Market Size by Country (2017-2022) 8.3 Asia-Pacific Molecular Diagnosis and Therapy Market Size by Country (2023-2028) 8.4 China 8.5 Japan 8.6 South Korea 8.7 Southeast Asia 8.8 India 8.9 Australia 9 Latin America 9.1 Latin America Molecular Diagnosis and Therapy Market Size (2017-2028) 9.2 Latin America Molecular Diagnosis and Therapy Market Size by Country (2017-2022) 9.3 Latin America Molecular Diagnosis and Therapy Market Size by Country (2023-2028) 9.4 Mexico 9.5 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Molecular Diagnosis and Therapy Market Size (2017-2028) 10.2 Middle East & Africa Molecular Diagnosis and Therapy Market Size by Country (2017-2022) 10.3 Middle East & Africa Molecular Diagnosis and Therapy Market Size by Country (2023-2028) 10.4 Turkey 10.5 Saudi Arabia 10.6 UAE 11 Key Players Profiles 11.1 Abbott Laboratories 11.1.1 Abbott Laboratories Company Detail 11.1.2 Abbott Laboratories Business Overview 11.1.3 Abbott Laboratories Molecular Diagnosis and Therapy Introduction 11.1.4 Abbott Laboratories Revenue in Molecular Diagnosis and Therapy Business (2017-2022) 11.1.5 Abbott Laboratories Recent Development 11.2 Agilent Technologies 11.2.1 Agilent Technologies Company Detail 11.2.2 Agilent Technologies Business Overview 11.2.3 Agilent Technologies Molecular Diagnosis and Therapy Introduction 11.2.4 Agilent Technologies Revenue in Molecular Diagnosis and Therapy Business (2017-2022) 11.2.5 Agilent Technologies Recent Development 11.3 Becton, Dickinson and Company 11.3.1 Becton, Dickinson and Company Company Detail 11.3.2 Becton, Dickinson and Company Business Overview 11.3.3 Becton, Dickinson and Company Molecular Diagnosis and Therapy Introduction 11.3.4 Becton, Dickinson and Company Revenue in Molecular Diagnosis and Therapy Business (2017-2022) 11.3.5 Becton, Dickinson and Company Recent Development 11.4 Biomérieux Sa 11.4.1 Biomérieux Sa Company Detail 11.4.2 Biomérieux Sa Business Overview 11.4.3 Biomérieux Sa Molecular Diagnosis and Therapy Introduction 11.4.4 Biomérieux Sa Revenue in Molecular Diagnosis and Therapy Business (2017-2022) 11.4.5 Biomérieux Sa Recent Development 11.5 Danaher Corporation 11.5.1 Danaher Corporation Company Detail 11.5.2 Danaher Corporation Business Overview 11.5.3 Danaher Corporation Molecular Diagnosis and Therapy Introduction 11.5.4 Danaher Corporation Revenue in Molecular Diagnosis and Therapy Business (2017-2022) 11.5.5 Danaher Corporation Recent Development 11.6 Diasorin 11.6.1 Diasorin Company Detail 11.6.2 Diasorin Business Overview 11.6.3 Diasorin Molecular Diagnosis and Therapy Introduction 11.6.4 Diasorin Revenue in Molecular Diagnosis and Therapy Business (2017-2022) 11.6.5 Diasorin Recent Development 11.7 Grifols 11.7.1 Grifols Company Detail 11.7.2 Grifols Business Overview 11.7.3 Grifols Molecular Diagnosis and Therapy Introduction 11.7.4 Grifols Revenue in Molecular Diagnosis and Therapy Business (2017-2022) 11.7.5 Grifols Recent Development 11.8 Hologic 11.8.1 Hologic Company Detail 11.8.2 Hologic Business Overview 11.8.3 Hologic Molecular Diagnosis and Therapy Introduction 11.8.4 Hologic Revenue in Molecular Diagnosis and Therapy Business (2017-2022) 11.8.5 Hologic Recent Development 11.9 Illumina 11.9.1 Illumina Company Detail 11.9.2 Illumina Business Overview 11.9.3 Illumina Molecular Diagnosis and Therapy Introduction 11.9.4 Illumina Revenue in Molecular Diagnosis and Therapy Business (2017-2022) 11.9.5 Illumina Recent Development 11.10 Qiagen 11.10.1 Qiagen Company Detail 11.10.2 Qiagen Business Overview 11.10.3 Qiagen Molecular Diagnosis and Therapy Introduction 11.10.4 Qiagen Revenue in Molecular Diagnosis and Therapy Business (2017-2022) 11.10.5 Qiagen Recent Development 11.11 Roche Diagnostics 11.11.1 Roche Diagnostics Company Detail 11.11.2 Roche Diagnostics Business Overview 11.11.3 Roche Diagnostics Molecular Diagnosis and Therapy Introduction 11.11.4 Roche Diagnostics Revenue in Molecular Diagnosis and Therapy Business (2017-2022) 11.11.5 Roche Diagnostics Recent Development 11.12 Siemens AG 11.12.1 Siemens AG Company Detail 11.12.2 Siemens AG Business Overview 11.12.3 Siemens AG Molecular Diagnosis and Therapy Introduction 11.12.4 Siemens AG Revenue in Molecular Diagnosis and Therapy Business (2017-2022) 11.12.5 Siemens AG Recent Development 11.13 Thermo Fisher Scientific 11.13.1 Thermo Fisher Scientific Company Detail 11.13.2 Thermo Fisher Scientific Business Overview 11.13.3 Thermo Fisher Scientific Molecular Diagnosis and Therapy Introduction 11.13.4 Thermo Fisher Scientific Revenue in Molecular Diagnosis and Therapy Business (2017-2022) 11.13.5 Thermo Fisher Scientific Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details
List of Tables Table 1. Global Molecular Diagnosis and Therapy Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028 Table 2. Key Players of PCR Table 3. Key Players of DNA Sequencing Table 4. Key Players of NGS Table 5. Global Molecular Diagnosis and Therapy Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028 Table 6. Global Molecular Diagnosis and Therapy Market Size by Region (US$ Million): 2017 VS 2021 VS 2028 Table 7. Global Molecular Diagnosis and Therapy Market Size by Region (2017-2022) & (US$ Million) Table 8. Global Molecular Diagnosis and Therapy Market Share by Region (2017-2022) Table 9. Global Molecular Diagnosis and Therapy Forecasted Market Size by Region (2023-2028) & (US$ Million) Table 10. Global Molecular Diagnosis and Therapy Market Share by Region (2023-2028) Table 11. Molecular Diagnosis and Therapy Market Trends Table 12. Molecular Diagnosis and Therapy Market Drivers Table 13. Molecular Diagnosis and Therapy Market Challenges Table 14. Molecular Diagnosis and Therapy Market Restraints Table 15. Global Molecular Diagnosis and Therapy Revenue by Players (2017-2022) & (US$ Million) Table 16. Global Molecular Diagnosis and Therapy Market Share by Players (2017-2022) Table 17. Global Top Molecular Diagnosis and Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Molecular Diagnosis and Therapy as of 2021) Table 18. Ranking of Global Top Molecular Diagnosis and Therapy Companies by Revenue (US$ Million) in 2021 Table 19. Global 5 Largest Players Market Share by Molecular Diagnosis and Therapy Revenue (CR5 and HHI) & (2017-2022) Table 20. Key Players Headquarters and Area Served Table 21. Key Players Molecular Diagnosis and Therapy Product Solution and Service Table 22. Date of Enter into Molecular Diagnosis and Therapy Market Table 23. Mergers & Acquisitions, Expansion Plans Table 24. Global Molecular Diagnosis and Therapy Market Size by Type (2017-2022) & (US$ Million) Table 25. Global Molecular Diagnosis and Therapy Revenue Market Share by Type (2017-2022) Table 26. Global Molecular Diagnosis and Therapy Forecasted Market Size by Type (2023-2028) & (US$ Million) Table 27. Global Molecular Diagnosis and Therapy Revenue Market Share by Type (2023-2028) Table 28. Global Molecular Diagnosis and Therapy Market Size by Application (2017-2022) & (US$ Million) Table 29. Global Molecular Diagnosis and Therapy Revenue Market Share by Application (2017-2022) Table 30. Global Molecular Diagnosis and Therapy Forecasted Market Size by Application (2023-2028) & (US$ Million) Table 31. Global Molecular Diagnosis and Therapy Revenue Market Share by Application (2023-2028) Table 32. North America Molecular Diagnosis and Therapy Market Size by Country (2017-2022) & (US$ Million) Table 33. North America Molecular Diagnosis and Therapy Market Size by Country (2023-2028) & (US$ Million) Table 34. Europe Molecular Diagnosis and Therapy Market Size by Country (2017-2022) & (US$ Million) Table 35. Europe Molecular Diagnosis and Therapy Market Size by Country (2023-2028) & (US$ Million) Table 36. Asia-Pacific Molecular Diagnosis and Therapy Market Size by Region (2017-2022) & (US$ Million) Table 37. Asia-Pacific Molecular Diagnosis and Therapy Market Size by Region (2023-2028) & (US$ Million) Table 38. Latin America Molecular Diagnosis and Therapy Market Size by Country (2017-2022) & (US$ Million) Table 39. Latin America Molecular Diagnosis and Therapy Market Size by Country (2023-2028) & (US$ Million) Table 40. Middle East & Africa Molecular Diagnosis and Therapy Market Size by Country (2017-2022) & (US$ Million) Table 41. Middle East & Africa Molecular Diagnosis and Therapy Market Size by Country (2023-2028) & (US$ Million) Table 42. Abbott Laboratories Company Detail Table 43. Abbott Laboratories Business Overview Table 44. Abbott Laboratories Molecular Diagnosis and Therapy Product Table 45. Abbott Laboratories Revenue in Molecular Diagnosis and Therapy Business (2017-2022) & (US$ Million) Table 46. Abbott Laboratories Recent Development Table 47. Agilent Technologies Company Detail Table 48. Agilent Technologies Business Overview Table 49. Agilent Technologies Molecular Diagnosis and Therapy Product Table 50. Agilent Technologies Revenue in Molecular Diagnosis and Therapy Business (2017-2022) & (US$ Million) Table 51. Agilent Technologies Recent Development Table 52. Becton, Dickinson and Company Company Detail Table 53. Becton, Dickinson and Company Business Overview Table 54. Becton, Dickinson and Company Molecular Diagnosis and Therapy Product Table 55. Becton, Dickinson and Company Revenue in Molecular Diagnosis and Therapy Business (2017-2022) & (US$ Million) Table 56. Becton, Dickinson and Company Recent Development Table 57. Biomérieux Sa Company Detail Table 58. Biomérieux Sa Business Overview Table 59. Biomérieux Sa Molecular Diagnosis and Therapy Product Table 60. Biomérieux Sa Revenue in Molecular Diagnosis and Therapy Business (2017-2022) & (US$ Million) Table 61. Biomérieux Sa Recent Development Table 62. Danaher Corporation Company Detail Table 63. Danaher Corporation Business Overview Table 64. Danaher Corporation Molecular Diagnosis and Therapy Product Table 65. Danaher Corporation Revenue in Molecular Diagnosis and Therapy Business (2017-2022) & (US$ Million) Table 66. Danaher Corporation Recent Development Table 67. Diasorin Company Detail Table 68. Diasorin Business Overview Table 69. Diasorin Molecular Diagnosis and Therapy Product Table 70. Diasorin Revenue in Molecular Diagnosis and Therapy Business (2017-2022) & (US$ Million) Table 71. Diasorin Recent Development Table 72. Grifols Company Detail Table 73. Grifols Business Overview Table 74. Grifols Molecular Diagnosis and Therapy Product Table 75. Grifols Revenue in Molecular Diagnosis and Therapy Business (2017-2022) & (US$ Million) Table 76. Grifols Recent Development Table 77. Hologic Company Detail Table 78. Hologic Business Overview Table 79. Hologic Molecular Diagnosis and Therapy Product Table 80. Hologic Revenue in Molecular Diagnosis and Therapy Business (2017-2022) & (US$ Million) Table 81. Hologic Recent Development Table 82. Illumina Company Detail Table 83. Illumina Business Overview Table 84. Illumina Molecular Diagnosis and Therapy Product Table 85. Illumina Revenue in Molecular Diagnosis and Therapy Business (2017-2022) & (US$ Million) Table 86. Illumina Recent Development Table 87. Qiagen Company Detail Table 88. Qiagen Business Overview Table 89. Qiagen Molecular Diagnosis and Therapy Product Table 90. Qiagen Revenue in Molecular Diagnosis and Therapy Business (2017-2022) & (US$ Million) Table 91. Qiagen Recent Development Table 92. Roche Diagnostics Company Detail Table 93. Roche Diagnostics Business Overview Table 94. Roche Diagnostics Molecular Diagnosis and TherapyProduct Table 95. Roche Diagnostics Revenue in Molecular Diagnosis and Therapy Business (2017-2022) & (US$ Million) Table 96. Roche Diagnostics Recent Development Table 97. Siemens AG Company Detail Table 98. Siemens AG Business Overview Table 99. Siemens AG Molecular Diagnosis and TherapyProduct Table 100. Siemens AG Revenue in Molecular Diagnosis and Therapy Business (2017-2022) & (US$ Million) Table 101. Siemens AG Recent Development Table 102. Thermo Fisher Scientific Company Detail Table 103. Thermo Fisher Scientific Business Overview Table 104. Thermo Fisher Scientific Molecular Diagnosis and TherapyProduct Table 105. Thermo Fisher Scientific Revenue in Molecular Diagnosis and Therapy Business (2017-2022) & (US$ Million) Table 106. Thermo Fisher Scientific Recent Development Table 107. Research Programs/Design for This Report Table 108. Key Data Information from Secondary Sources Table 109. Key Data Information from Primary Sources List of Figures Figure 1. Global Molecular Diagnosis and Therapy Market Share by Type: 2021 VS 2028 Figure 2. PCR Features Figure 3. DNA Sequencing Features Figure 4. NGS Features Figure 5. Global Molecular Diagnosis and Therapy Market Share by Application in 2021 & 2028 Figure 6. Diagnostic Laboratories Case Studies Figure 7. Research & Academic Laboratories Case Studies Figure 8. Molecular Diagnosis and Therapy Report Years Considered Figure 9. Global Molecular Diagnosis and Therapy Market Size (US$ Million), Year-over-Year: 2017-2028 Figure 10. Global Molecular Diagnosis and Therapy Market Size, (US$ Million), 2017 VS 2021 VS 2028 Figure 11. Global Molecular Diagnosis and Therapy Market Share by Region: 2021 VS 2028 Figure 12. Global Molecular Diagnosis and Therapy Market Share by Players in 2021 Figure 13. Global Top Molecular Diagnosis and Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Molecular Diagnosis and Therapy as of 2021) Figure 14. The Top 10 and 5 Players Market Share by Molecular Diagnosis and Therapy Revenue in 2021 Figure 15. North America Molecular Diagnosis and Therapy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 16. North America Molecular Diagnosis and Therapy Market Share by Country (2017-2028) Figure 17. United States Molecular Diagnosis and Therapy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 18. Canada Molecular Diagnosis and Therapy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 19. Europe Molecular Diagnosis and Therapy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 20. Europe Molecular Diagnosis and Therapy Market Share by Country (2017-2028) Figure 21. Germany Molecular Diagnosis and Therapy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 22. France Molecular Diagnosis and Therapy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 23. U.K. Molecular Diagnosis and Therapy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 24. Italy Molecular Diagnosis and Therapy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 25. Russia Molecular Diagnosis and Therapy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 26. Nordic Countries Molecular Diagnosis and Therapy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 27. Asia-Pacific Molecular Diagnosis and Therapy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 28. Asia-Pacific Molecular Diagnosis and Therapy Market Share by Region (2017-2028) Figure 29. China Molecular Diagnosis and Therapy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 30. Japan Molecular Diagnosis and Therapy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 31. South Korea Molecular Diagnosis and Therapy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 32. Southeast Asia Molecular Diagnosis and Therapy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 33. India Molecular Diagnosis and Therapy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 34. Australia Molecular Diagnosis and Therapy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 35. Latin America Molecular Diagnosis and Therapy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 36. Latin America Molecular Diagnosis and Therapy Market Share by Country (2017-2028) Figure 37. Mexico Molecular Diagnosis and Therapy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 38. Brazil Molecular Diagnosis and Therapy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 39. Middle East & Africa Molecular Diagnosis and Therapy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 40. Middle East & Africa Molecular Diagnosis and Therapy Market Share by Country (2017-2028) Figure 41. Turkey Molecular Diagnosis and Therapy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 42. Saudi Arabia Molecular Diagnosis and Therapy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 43. Abbott Laboratories Revenue Growth Rate in Molecular Diagnosis and Therapy Business (2017-2022) Figure 44. Agilent Technologies Revenue Growth Rate in Molecular Diagnosis and Therapy Business (2017-2022) Figure 45. Becton, Dickinson and Company Revenue Growth Rate in Molecular Diagnosis and Therapy Business (2017-2022) Figure 46. Biomérieux Sa Revenue Growth Rate in Molecular Diagnosis and Therapy Business (2017-2022) Figure 47. Danaher Corporation Revenue Growth Rate in Molecular Diagnosis and Therapy Business (2017-2022) Figure 48. Diasorin Revenue Growth Rate in Molecular Diagnosis and Therapy Business (2017-2022) Figure 49. Grifols Revenue Growth Rate in Molecular Diagnosis and Therapy Business (2017-2022) Figure 50. Hologic Revenue Growth Rate in Molecular Diagnosis and Therapy Business (2017-2022) Figure 51. Illumina Revenue Growth Rate in Molecular Diagnosis and Therapy Business (2017-2022) Figure 52. Qiagen Revenue Growth Rate in Molecular Diagnosis and Therapy Business (2017-2022) Figure 53. Roche Diagnostics Revenue Growth Rate in Molecular Diagnosis and Therapy Business (2017-2022) Figure 54. Siemens AG Revenue Growth Rate in Molecular Diagnosis and Therapy Business (2017-2022) Figure 55. Thermo Fisher Scientific Revenue Growth Rate in Molecular Diagnosis and Therapy Business (2017-2022) Figure 56. Bottom-up and Top-down Approaches for This Report Figure 57. Data Triangulation Figure 58. Key Executives Interviewed
Abbott Laboratories Agilent Technologies Becton, Dickinson and Company Biomérieux Sa Danaher Corporation Diasorin Grifols Hologic Illumina Qiagen Roche Diagnostics Siemens AG Thermo Fisher Scientific
The research report includes specific segments by region (country), by manufacturers, by Type and ... Read More
The research report includes specific segments by region (country), by manufacturers, by Type and ... Read More
The research report includes specific segments by region (country), by manufacturers, by Type and ... Read More
The research report includes specific segments by region (country), by manufacturers, by Type and ... Read More